Today, the Assembly Financial Institutions & Insurance Committee voted to improve New Jerseyans’ access to biomarker testing, advancing Assembly Bill 4163 out of committee. Championed by Assemblymembers Shavonda Sumter, Gary Schaer and Shama Haider, the proposal would ensure biomarker testing is covered by New Jersey-regulated insurance plans, including Medicaid, when medical and scientific evidence shows it would provide a benefit to patients. Advocates now look to the full Assembly to favorably advance Assembly Bill 4163 to the Senate.